The IPO Buzz: CytoMed Therapeutics Prices its Micro-Cap IPO at $4.00 – Low End
CytoMed Therapeutics Limited (GDTC) priced its micro-cap IPO at $4.00 – the low end of its $4.00-to-$5.00 price range – on 2.41 million ordinary shares – the same number (2,412,369 shares) as in the prospectus – on Thursday night (April 13, 2023). The Malaysian pre-clinical cancer biotech’s IPO raised $9.65 million. The stock in the […]
April 13, 2023 Read More